Invention Grant
- Patent Title: 2-acylaminothiazoles for the treatment of cancer
-
Application No.: US14902319Application Date: 2014-07-03
-
Publication No.: US09708279B2Publication Date: 2017-07-18
- Inventor: Carlo Gambacorti-Passerini , Luca Mologni , Leonardo Scapozza , William Bisson , Peter Goekjian , Joseph D'Attoma
- Applicant: UNIVERSITA′ DEGLI STUDI DI MILANO-BICOCCA , UNIVERSITÈ DE GENÈVE , UNIVERSITÈ CLAUDE BERNARD LYON 1
- Applicant Address: IT Milan CH Geneva FR Villeurbanne
- Assignee: UNIVERSITÁ DEGLI STUDI DI MILANO—BICOCCA,UNIVERSITÈ DE GENÈVE,UNIVERSITÈ CLAUDE BERNARD LYON 1
- Current Assignee: UNIVERSITÁ DEGLI STUDI DI MILANO—BICOCCA,UNIVERSITÈ DE GENÈVE,UNIVERSITÈ CLAUDE BERNARD LYON 1
- Current Assignee Address: IT Milan CH Geneva FR Villeurbanne
- Agency: Arent Fox LLP
- Priority: ITMI2013A1124 20130704
- International Application: PCT/EP2014/064197 WO 20140703
- International Announcement: WO2015/001024 WO 20150108
- Main IPC: C07D277/46
- IPC: C07D277/46 ; C07D417/12 ; C07D417/14 ; C07F7/08 ; C07F7/18 ; A61K31/421 ; A61K31/427 ; A61K31/496 ; A61K31/5377
Abstract:
The present invention relates to inhibitors of the oncogenic protein kinase ALK of formula (I): as herein described and pharmaceutical compositions thereof. The compounds of formula (I) are useful in the preparation of a medicament, in particular for the treatment of cancer.
Public/Granted literature
- US20160257658A1 2-ACYLAMINOTHIAZOLES FOR THE TREATMENT OF CANCER Public/Granted day:2016-09-08
Information query
